Why Post-Market Surveillance Is the Real Test of Medical Device Safety
Effective post-market surveillance depends on HTM teams to bridge the gap between regulatory oversight and real-world performance.
Effective post-market surveillance depends on HTM teams to bridge the gap between regulatory oversight and real-world performance.
IRadimed Corp. issued an Urgent Medical Device Correction Letter regarding a potential issue with some 1057 Syringe Adapter Sets.
Two congressmen introduced a bill to improve the FDA process of reporting an adverse health event, or safety signal, due to a medical device.
Effective post-market surveillance depends on HTM teams to bridge the gap between regulatory oversight and real-world performance.
A VA Medical center briefly halted medical procedures this year after discovering concerns involving the reprocessing of reusable medical equipment.
Read MoreThe new advisory highlights the importance of how surgical instruments and other critical devices are reprocessed and reused every day in healthcare.
Read MoreCORL launched a medical device security assessment toolkit to combat medical device and IoT risks that may be introduced by third-party vendors.
Read MoreMedical researchers are calling on the U.S. FDA to place more emphasis on initiating conformity of medical device interoperability in the healthcare industry.
Read MoreIn October 2015, Canadian Paul Johnson underwent open heart surgery to correct a defect in his aortic value. Unfortunately, the surgery didn’t go as expected due to a contaminated medical device. And now litigation is pending.
Read MoreThe plan seeks to strengthen regulatory science and identify current and emerging issues in medical device research and regulation for women’s health.
Read MoreProject Embrace offers the provision of necessary medical resources to low-income, isolated, marginalized, or low-resource communities.